𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia – a randomized, double-blind, placebo-controlled study

✍ Scribed by P. GINÈS; F. WONG; H. WATSON; R. TERG; R. BRUHA; J.-P. ZARSKI; F. DUDLEY; FOR THE NORMOCAT STUDY INVESTIGATORS1

Book ID
108605860
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
201 KB
Volume
31
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of satavaptan, a selective vasop
Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: A randomized trial
✍ Pere Ginès; Florence Wong; Hugh Watson; Slobodan Milutinovic; Luis Ruiz del Arbo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Hyponatremia in cirrhosis is associated with significant morbidity and mortality and complicates ascites management. Vasopressin receptor antagonists improve serum sodium concentration by increasing renal solute-free water excretion, but their effects on the management of ascites have not been asses